Global Next-Generation Sequencing Data Analysis Market Poised for 21.7 % Growth, Surpassing $3.24 Billion by 2029

What is the present valuation and projected CAGR of the next-generation sequencing data analysis market?

The next-generation sequencing data analysis market size has grown exponentially in recent years. It will grow from $1.21 $ billion in 2024 to $1.48 $ billion in 2025 at a compound annual growth rate (CAGR) of 22.0%. The growth in the historic period can be attributed to increasing use for pathogen detection, adoption in veterinary diagnostics and research, increasing use for diagnosing rare genetic disorders, increasing focus on microbiome research, and increasing use of NGS in pharmacogenomics.

The next-generation sequencing data analysis market size is expected to see exponential growth in the next few years. It will grow to $3.24 $ billion in 2029 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to a rising focuses on integrating genomics into healthcare, educating healthcare professionals, focusing on public health surveillance, reducing sequencing costs, and rising interest in epigenetic studies. Major trends in the forecast period include advances in single-cell sequencing, automation in NGS data analysis, development in visualization tools for NGS data, adoption of blockchain technology, and advancement in hybrid sequencing techniques.

Get Your Free Sample of The Global Next-Generation Sequencing Data Analysis Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19614&type=smp

What key drivers have fueled the next-generation sequencing data analysis market’s development over the years?

The increasing cancer prevalence is expected to propel the growth of the next-generation sequencing data analysis market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body, which can potentially lead to serious health complications or death if not treated. Poor lifestyle habits, including smoking, excessive alcohol consumption, and diets rich in processed foods and low in fruits and vegetables, can significantly increase the risk of cancer. Next-generation sequencing data analysis helps cancer treatment by enabling precise identification of genetic mutations, leading to personalized therapies and more effective treatment strategies tailored to the specific genetic profile of an individual’s cancer. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing cancer prevalence is driving the growth of the next-generation sequencing data analysis market.

What is the segmentation for the next-generation sequencing data analysis market?

The next-generation sequencing data analysismarket covered in this report is segmented –

1) By Product: Services, Next-Generation Sequencing (NGS) Commercial Software

2) By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing

3) By Mode: In-House, Outsourced

4) By Workflow: Primary, Secondary, Tertiary

5) By End-User: Academic Research, Clinical Research, Hospitals And Clinics, Pharma And Biotech Entities, Other End-Users

Subsegments:

1) By Services: Data Analysis Services, Bioinformatics Services, Consulting Services, Sample Preparation Services, Training and Support Services

2) By Next-Generation Sequencing (NGS) Commercial Software: Data Management Software, Alignment Software, Variant Calling Software, Visualization Software, Pipeline Management Software, Specialized Analysis Software

Order your report now for swift delivery

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-data-analysis-global-market-report

Who are the most influential companies in the next-generation sequencing data analysis market?

Major companies operating in the next-generation sequencing data analysis market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., MedGenome Inc., Element Biosciences Inc., Seven Bridges Genomics Inc., Synthego Corp., Eurofins Genomics India Pvt. Ltd., Fabric Genomics Inc., Strand Life Sciences Pvt. Ltd., Admera Health LLC, Congenica Ltd., DNASTAR Inc., Golden Helix Inc., Geneious, SciGenom Labs Pvt. Ltd., Partek Incorporated, PathoQuest SAS, BioDatomics Inc., BGI Genomics Co. Ltd

What are the top industry trends projected to impact the next-generation sequencing data analysis market?

Major companies operating in the next-generation sequencing data analysis market are focused on developing advanced secondary analysis bioinformatics software to enable faster and more precise identification of genetic variants for research and clinical applications. Secondary analysis bioinformatics software is designed to process raw sequencing data from next-generation sequencing (NGS) and convert it into interpretable formats, such as variant call files (VCF), which detail genetic variants. This software streamlines the analysis of NGS data for research and clinical purposes. For instance, in January 2024, QIAGEN Digital Insights, a US-based bioinformatics business of QIAGEN, launched the QIAGEN CLC Genomics Workbench Premium with LightSpeed technology. This software facilitates next-generation sequencing (NGS) for somatic cancer analysis and rapidly processes whole genome sequencing (WGS) samples. It can analyze 34x human genomes in 25 minutes and 50x exomes in 90 seconds using LightSpeed technology, which efficiently converts raw FASTQ data into interpretable formats. With costs as low as $1 for genomes and a few cents for exomes using cloud infrastructure, it’s a cost-effective solution for high-throughput labs. The program runs on ordinary hardware or cloud platforms, providing flexibility and excellent accuracy, making it ideal for clinical applications while minimizing its carbon footprint.

What are the major regional insights for the next-generation sequencing data analysis market, and which region holds the top position?

North America was the largest region in the next-generation sequencing data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Next-Generation Sequencing Data Analysis Market Report 2025 Offer?

The next-generation sequencing data analysis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Next-generation sequencing (NGS) data analysis is the process of understanding the large amounts of data generated by high-throughput sequencing technologies for DNA or RNA. Its primary purpose is to decipher genetic variants and mutations, which helps with illness detection, biomarker discovery, and biological process understanding. This study is critical for increasing customized medicine, focused treatments, and improving diagnostic precision.

Purchase the exclusive report now to unlock valuable market insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19614

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *